Skip to main content
Clinical Trials/KCT0001676
KCT0001676
Completed
未知

Investigation of the difference of radial artery pulse characteristics between the obesity and normal control group: exploratory clinical study

Korea Institute of Oriental Medicine0 sites57 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Korea Institute of Oriental Medicine
Enrollment
57
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Observational Study
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Premenopausal women aged from 20 to 45 lived in Gwangju or Jeonnam province.
  • 2\. Android obese type: body mass index (BMI) \= 25 kg/m2 and waist to hip ratio (WHR) \= 0\.90
  • 3\. Gynoid obese type: BMI \= 25 kg/m2 and WHR \<0\.85
  • 4\. Subjects who clearly understood the purpose and specificity after the full explanation of the study, and signed an informed consent with voluntary participation.

Exclusion Criteria

  • 1\. Patients with hypertension or subjects not diagnosed to hypertension but whose systolic blood pressure (SBP) is greater than 160 mmHg or diastolic blood pressure (DBP) is greater than 90 mmHg at the screening date.
  • 2\. Hyperlipidemia (LDL\-cholesterol \= 160 mg/dL or triglyceride \= 500 mg/dL)
  • 3\. Diabetes or subjects whose fasting blood glucose level is greater than 126 mg/dL at the screening date.
  • 4\. Endocrine diseases such as hypothyroidism or Cushing syndrome, which can be affect to individual's weight.
  • 5\. Cardiovascular disease (heart failure, angina pectoris, myocardial infarction, and aherosclerotic heart disease) or with transplant of electric devices such as pacemaker.
  • 6\. Malignant neoplasm or lung diseases.
  • 7\. Severe renal disease (creatinine \> 2\.0 mg/dL)
  • 8\. Liver function disorder (alanine transaminase (ALT) or asparate aminotransferase (AST) is greater than 2\.5 folds from the maximum of normal range)
  • 9\. Musculoskeletal complication or rheumatoid disease
  • 10\. Mental disorder: depression, anxiety neurosis, schizophrenia, eating disorder, alcoholism, continuous drug use.

Outcomes

Primary Outcomes

Not specified

Similar Trials